IL17A and neoplasm: This is consistent with previous studies in which IL-17 promotes PD-L1 expression in tumor cells by activating STAT3 signaling and recruiting both myeloid suppressor cells (MDSCs) and regulatory T cells (Tregs) to form an immunosuppressive microenvironment (47, 48).